Medicare enrollment is the single largest barrier to entry in the DME industry —
a 6–12 month gauntlet of documentation, site inspections, and review queues
before a single claim can be billed. This acquisition eliminates that entirely.
The entity comes fully credentialed: active DME licensure, Medicare contracts in
place, and an issued PTAN with a clean, zero-claims billing history.
From day
one, the buyer holds what competitors will spend the better part of a year
pursuing.
The underlying market is one of the most durable in healthcare. An aging
population drives consistent, non-discretionary demand for wheelchairs, hospital
beds, oxygen equipment, and related devices — much of it on recurring rental
revenue models.
For an investor, that combination of immediate operational
capability and structurally growing demand is rare at this entry point.
Best suited for healthcare investors seeking recurring-revenue exposure, medical
professionals adding a supply arm, or operators entering the space who value
time-to-revenue over building from scratch.